Aytu BioScience, Inc. (AYTU): Price and Financial Metrics

Aytu BioScience, Inc. (AYTU): $1.94

0.02 (+0.91%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add AYTU to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#38 of 345

in industry

AYTU Price/Volume Stats

Current price $1.94 52-week high $3.45
Prev. close $1.92 52-week low $1.90
Day low $1.91 Volume 9,000
Day high $2.03 Avg. volume 20,416
50-day MA $2.34 Dividend yield N/A
200-day MA $2.76 Market Cap 11.91M

AYTU Stock Price Chart Interactive Chart >


Aytu BioScience, Inc. (AYTU) Company Bio


Aytu BioScience, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company markets Natesto, a nasal gel for the treatment of hypogonadism (low testosterone) in men; and Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension. It also offers ZolpiMist, an oral spray for the treatment of insomnia; and MiOXSYS, an in vitro diagnostic semen analysis test that is used in the measurement of static oxidation reduction potential in human semen. Aytu BioScience, Inc. is based in Englewood, Colorado.


AYTU Latest News Stream


Event/Time News Detail
Loading, please wait...

AYTU Latest Social Stream


Loading social stream, please wait...

View Full AYTU Social Stream

AYTU Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Continue Researching AYTU

Here are a few links from around the web to help you further your research on Aytu Bioscience Inc's stock as an investment opportunity:

Aytu Bioscience Inc (AYTU) Stock Price | Nasdaq
Aytu Bioscience Inc (AYTU) Stock Quote, History and News - Yahoo Finance
Aytu Bioscience Inc (AYTU) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!